• closedAccess   Efficacy and tolerability of EH301 for amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled human pilot study 

      de la Rubia, José E.; Drehmer, Eraci; Platero, José L.; Benlloch, María; Caplliure-Llopis, Jordi; Villaron-Casales, Carlos; de Bernardo, Nieves; Alarcón, Jorge; Fuente, Cristian; Carrera, Sandra; Sancho, David; García-Pardo, Pilar; Pascual, Raquel; Juárez, Marta; Cuerda-Ballester, María; Forner, Alfonso; Sancho-Castillo, Sandra; Barrios, Carlos; Obrador, Elena; Marchio, Patricia; Salvador, Rosario; Holmes, Holly E.; Dellinger, Ryan W.; Guarente, Leonard; Estrela, José M. Taylor & Francis (2019)
      Background: Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease, characterized by progressive loss of spinal and cortical motor neurons, leading to muscular atrophy, respiratory failure, and ...